Skip to main content
icon for CDC emite aviso de Nível 3 até 31 de dezembro?
Clima E Ciência·Pandemias

CDC emite aviso de Nível 3 até 31 de dezembro?

icon for CDC emite aviso de Nível 3 até 31 de dezembro?
Clima E Ciência·Pandemias

CDC emite aviso de Nível 3 até 31 de dezembro?

dez 31

dez 31

Sim

76% chance
Polymarket

$117,038 Vol.

Sim

76% chance
Polymarket

$117,038 Vol.

This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution. The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.The recent multi-country hantavirus outbreak—eight cases including three deaths from Andes virus linked to the MV Hondius cruise ship in the South Atlantic, confirmed by WHO on May 6—has driven Polymarket's 75.5% implied probability for a CDC Level 3 Travel Health Notice by December 31, as traders anticipate potential escalation amid CDC's Health Alert Network advisory (HAN-00528) and Emergency Operations Center activation at its lowest Level 3 tier for monitoring. No Level 3 notices are active per CDC's latest update, though ongoing Level 2 alerts for meningococcal disease in the Democratic Republic of the Congo, clade II mpox in Ghana and Liberia, and persistent H5N1 reservoirs in U.S. wild birds and poultry signal elevated outbreak risks. Epidemiological surveillance and seasonal transmission dynamics remain pivotal, with model projections highlighting uncertainty in human-to-human spread thresholds.

This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.

The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Volume
$117,038
Data de Término
31 dez 2026
Mercado Aberto
Jan 19, 2026, 3:15 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution. The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution. The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.The recent multi-country hantavirus outbreak—eight cases including three deaths from Andes virus linked to the MV Hondius cruise ship in the South Atlantic, confirmed by WHO on May 6—has driven Polymarket's 75.5% implied probability for a CDC Level 3 Travel Health Notice by December 31, as traders anticipate potential escalation amid CDC's Health Alert Network advisory (HAN-00528) and Emergency Operations Center activation at its lowest Level 3 tier for monitoring. No Level 3 notices are active per CDC's latest update, though ongoing Level 2 alerts for meningococcal disease in the Democratic Republic of the Congo, clade II mpox in Ghana and Liberia, and persistent H5N1 reservoirs in U.S. wild birds and poultry signal elevated outbreak risks. Epidemiological surveillance and seasonal transmission dynamics remain pivotal, with model projections highlighting uncertainty in human-to-human spread thresholds.

This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.

The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Volume
$117,038
Data de Término
31 dez 2026
Mercado Aberto
Jan 19, 2026, 3:15 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution. The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.

Cuidado com os links externos.

Frequently Asked Questions

"CDC emite aviso de Nível 3 até 31 de dezembro?" is a prediction market on Polymarket with 2 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "O CDC emite alerta de Nível 3 até 31 de dezembro?" at 76%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 76¢ implies that the market collectively assigns a 76% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

As of today, "CDC emite aviso de Nível 3 até 31 de dezembro?" has generated $117K in total trading volume since the market launched on Jan 19, 2026. This level of trading activity reflects strong engagement from the Polymarket community and helps ensure that the current odds are informed by a deep pool of market participants. You can track live price movements and trade on any outcome directly on this page.

To trade on "CDC emite aviso de Nível 3 até 31 de dezembro?," browse the 2 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current frontrunner for "CDC emite aviso de Nível 3 até 31 de dezembro?" is "O CDC emite alerta de Nível 3 até 31 de dezembro?" at 76%, meaning the market assigns a 76% chance to that outcome. These odds update in real-time as traders buy and sell shares, so they reflect the latest collective view of what's most likely to happen. Check back frequently or bookmark this page to follow how the odds shift as new information emerges.

The resolution rules for "CDC emite aviso de Nível 3 até 31 de dezembro?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.